Brazil's ANS lifts suspension on Hapvida price adjustments and contract cancellations

The Brazilian National Regulatory Agency for Private Health Insurance (ANS) has revoked a previous suspension that prevented Hapvida from implementing price adjustments and cancelling contracts. This reversal allows the insurer to resume standard billing and contract management practices, though the specific rationale for the initial suspension and subsequent lifting remains under regulatory review.